促销时间表 Conduit Pharmaceuticals Inc.
先进的时间表
简单图表
关于公司 Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.| IPO date | 2023-09-25 |
|---|---|
| ISIN | US20678X1063 |
| Industry | Life Sciences Tools & Services |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.conduitpharma.com |
| Цена ао | 0.85 |
| 每日价格变化: | +15.89% (0.768) |
|---|---|
| 每周价格变化: | +7.74% (0.8261) |
| 每月价格变化: | -23.28% (1.16) |
| 3个月内价格变化: | +1 380.87% (0.0601) |
| 六个月内的价格变化: | +651.05% (0.1185) |
| 每年价格变化: | -75.75% (3.67) |
| 年初以来价格变化: | +1 069.51% (0.0761) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Bank of Montreal/Can/ | 10000 | 0.01 |
| Kepos Capital LP | 1500 | 0 |
| Wells Fargo & Company | 72 | 0 |
| Morgan Stanley | 25 | 0 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00079 | 17.09 | 1.54048 |
iShares Russell 2000 Growth ETF
|
0.00012 | 38.04 | 0.6026 |
| 0 | 27.57 | 1.07 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Dr. David Joszef Tapolczay | CEO & Director | 419.8k | 1959 (66 年) |
| Dr. Joanne M. Holland | Chief Scientific Officer | N/A | 1975 (50 年) |
| Mr. James Bligh | Interim CFO & Director | 1988 (37 年) | |
| Mr. Bill Begien | Senior VP of Investor Relations |
地址: United States, San Diego. CA, 4995 Murphy Canyon Road - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.conduitpharma.com
网站: https://www.conduitpharma.com
